The Korea Atomic Energy Research Institute (KAERI) in Daejeon, South Korea was established in 1959 as the sole professional research-oriented institute for nuclear power in South Korea, and has rapidly built a reputation for research and development in various fields. In 1995 KAERI designed and constructed the nation's first multipurpose research reactor, HANARO based on the Canadian MAPLE design. KAERI is dedicated to finding a wide range of uses for atomic energy. As examples, KAERI developed the world's first radiopharmaceutical "Milican injection" for treating liver cancer.

Suzhou Tianrenhe Biotechnology Co., Ltd, established on 2007-09-04, Business scope includes pharmaceuticals,Health Supplies,food,Technology development of cosmetics,technology transfer,technical consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

Tianjin Yaoyu Biotechnology Co., Ltd., established on 2009-06-05, Business scope includes research and development of biological products,Technology transfer and technical consulting services;medical instruments,drug development,technical consulting,transfer;biological reagent(food,except medicines)Wholesale and retail;account Serive;Timber wholesale and retail;Self-operated and agency goods import and export and technology import and export;Wholesale and retail of prepackaged food and bulk food.(If the above business scope involves industry licensing, the license certificate,Operate within the validity period,If the state has monopoly regulations, it shall be handled according to the regulations).

The Children's Mercy Hospital provides pediatric health care services. It offers abdominal pain program, adolescent medicine, anesthesiology, bioethics, bone marrow transplantation, burn and trauma care, cardiology, child abuse and neglect, cleft palate and craniofacial, dentistry, dermatology, down syndrome clinic, eating disorders center, endocrinology and diabetes, epilepsy center, fetal health center, gastroenterology, genetics, gynecology, hand clinic and surgery, hematology, heart center, imaging, kidney and liver transplant, medical imaging, neonatology, neurology, nutrition services, ophthalmology, pain management, pathology and laboratory medicine, pharmacology, radiology, respiratory care, sexual differentiation treatment, sleep disorders program, surgery, telemedicine, urgent care, urologic surgery, and weight management services. The company was founded in June 1897 and is headquartered in Kansas City, MO.

Chengdu West China Precision Medicine Industry Technology Research Institute Co., Ltd., established on 2017-05-27, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Health Consulting Services(Does not include medical services);Intellectual Property Services(Except for patent agency services);Technology intermediary service;Science popularization service;3Dprint service;business management;Corporate Headquarters Management;Production of Class I Medical Devices;Sales of Class I Medical Devices;Class I Medical Device Leasing;Sales of Class II Medical Devices;Class II Medical Device Leasing(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Class III Medical Device Leasing;Drug Clinical Trial Services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Xinghuozhiyao (Beijing) Technology Co., Ltd., established on 2017-05-09, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Organize cultural and artistic exchange activities(without show);literary creation;Undertake exhibition and display activities;Conference Services;translation service;Computer System Services;Basic software service;Application software service(Does not contain medical software);product design;model design;Packaging and decoration design;Economic and Trade Consulting;public relations service;Conference Services;Fashion Design;Jewelry Design;arts and crafts design;computer graphic design,make;buisness planning;design,make,acting,Place an ad;market survey;Business Management Consulting;natural science research;Engineering and Technology Studies;Agricultural Science and Technology Research;Medical Research(Does not include medical activities);data processing(Bank Card Center in Data Processing,PUEvalue in1,5Except for the above cloud computing data centers);sell clothing,jewelry.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Suzhou Xinya Gene Biotechnology Co. Ltd. is a company headquartered in China that operates as biotechnology company.

Tian Qing Stem Cell Co., Ltd. engages in the stem cell extraction and storage services. It is mainly engaged in hematopoietic stem cell storage, umbilical cord mesenchymal stem cell storage, adipose stem cell storage, placental tissue storage and other clinical storage businesses. The company was founded on September 11, 2006 and is headquartered in Harbin, China.

Gaozhou People's Hospital is a Chinese private company located in Gaozhou. The firm operates medical and surgical hospitals.

Shandong Kaiti Biological Products Co., Ltd., established on 2018-10-22, Business scope includes biological products(In addition to vaccines)technology development,technology transfer,technical consulting,Technical Services;wholesale,retail:Biological product(In addition to vaccines),biological reagent;Import and export business(Excluding state trade management goods)and other legal,regulations,Items that are not prohibited by the State Council's decision and other regulations and do not require a business license.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Suzhou GenePharma Co.,Ltd. engages in the manufacture of biotechnology products. Its products cover chemically-synthetic RNA monomer, custom siRNA oligo, chemically-modified RNA oligo, fluorescent dye for biological macromolecules marker; Biosynthesis siRNA, shRNA; DNAs encoding shRNA, plasmid vector encoding shRNA; RNAi service based on chemical synthesis, RNAi service based on vector regulation; siRNA related reagents and RNA-related product sales; common molecular biology reagent and laboratory supplies sales. The company was founded on August 27, 2007 and is headquartered in Shanghai, China.

GenePharma (NEEQ: 430601) is a biotechnology company focusing on RNA based technologies and Pharmaceuticals. The company develops and provides innovative, reliable, high quality RNA related products, research and development (R&D) services.Their culture is defined by clear values: Integrity, Respect, Collaboration, and Innovation. GenePharma has established a comprehensive RNA manufacturing facility, and provides a wide range of open-access technology platforms and services including RNAi, gRNA, mRNA therapeutics, RNA biomarkers. These are all designed to enable efficient development of medicines for customers and support for contract researchprograms.The company's technology uses RNA made of nucleotide analogs targeting the key genes to produce therapeutic effect, synthetic gRNA based genome-editing and mRNA cancer vaccine to treat a wide range of diseases, including those that cannot be effectively treated with existing methods to develop and manufacture drugs.

Boao Biological Group Co., Ltd., established on 2000-09-30, The scope of business includes the production of instrumentation;6840In vitro diagnostic reagents,medical instruments,traditional Chinese medicine,biological reagent,Bioanalytical Instruments,biochip,Technology development of biochip accessory materials,Technical Services,Technology Promotion,technology transfer;software development;Basic software service,Application software service(Does not contain medical software);Sales instrumentation,Equipment,electronic product;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Import and export,Technology Import and Export,Agent import and export;Investment;investment management;lease commercial premises,office;Undertake the exhibition;Conference Services.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Wuhan Canvest Biotechnology Co., Ltd. engages in the businesses of biological product cell quality testing and biosafety assessment. It provides cell bank construction & preservation, cell verification, production process virus removal & inactivation verification, and corresponding third-party services for biosafety assessment. The company’s technical service items include bacteria & fungus sterility check, mycoplasma examination, internal & exogenous factor inspection, and tumorigenicity test. Wuhan Canvest Biotechnology was founded by Cong Yi Zheng, Geng Fu Xiao, Xiao Bing Xia, Xiang Dong Chen and Xiao Xiong Wu on April 20, 2011 and is headquartered in Wuhan, China.

ICCAS was founded in 1956. ICCAS is a multi-disciplinary research institute dedicated to the basic research in broad fields of chemical sciences, and to the key developments of the innovative high technologies aiming to the imperative national needs and important strategic targets, as well as to the collaborative high-technology applications and transfers. ICCAS is one of China’s leading chemistry research institutions with high international reputation.